SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-036558
Filing Date
2014-06-09
Accepted
2014-06-09 16:05:17
Documents
3
Period of Report
2014-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v380967_8k.htm 8-K 21355
2 EXHIBIT 10.1 v380967_ex10-1.htm EX-10.1 84521
3 GRAPHIC tpg12.jpg GRAPHIC 269406
  Complete submission text file 0001144204-14-036558.txt   478760
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54365 | Film No.: 14899242
SIC: 2836 Biological Products, (No Diagnostic Substances)